Postpartum Guillain-Barré Syndrome Presenting as Acute Motor Axonal Neuropathy in a Young Female: A Report of a Rare

Muhammad Maqbool1, Kuchi Deekshitha2, Doddapaneni D Chandana2

  • 1Internal Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, PAK.

Cureus
|November 4, 2024
PubMed

This case report presents a rare instance of acute motor axonal neuropathy (AMAN), a subtype of Guillain-Barré syndrome (GBS), in a 25-year-old postpartum female. The patient experienced a seven-day history of progressive, ascending motor weakness in all four limbs, beginning shortly before delivery and rapidly worsening postpartum. Notably, she exhibited no sensory deficits, a hallmark feature of AMAN, which was confirmed by nerve conduction studies revealing significant motor axonal involvement with preserved sensory function. The diagnostic process was complicated by the overlap of AMAN symptoms with other neurological conditions and the unusual postpartum context. Treatment with high-dose corticosteroids and plasmapheresis resulted in significant clinical improvement, underscoring the effectiveness of these interventions in managing AMAN. This case highlights the importance of considering AMAN in postpartum patients presenting with acute motor deficits, even in the absence of typical GBS sensory symptoms. It also emphasizes the need for early diagnosis and a multidisciplinary approach to optimize patient outcomes. By contributing to the limited literature on AMAN in postpartum women, this report aims to enhance clinical awareness, improve diagnostic accuracy, and inform treatment strategies for similar cases in the future.

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
661
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.7K